Bharat Biotech launches Nucelion, the next-gen cell and gene therapy CRDMO
Bharat Biotech International has announced the launch of Nucelion Therapeutics, a newly established, Hyderabad-based Contract…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Bharat Biotech
Bharat Biotech launches Biolumpivaxin, DIVA marker vaccine for lumpy skin disease
Vaccine has been demonstrated for the absence of reversion to virulence, safety, immunogenicity, protective efficacy and…
Dr Krishna M Ella recognised with INSA India Fellowship
This year a total of 61 fellowships were awarded, for the first time, the fellowships were awarded to Industry leaders
Bharat Biotech launches oral cholera vaccine HILLCHOL to address global shortage
New manufacturing facilities aim to bridge critical vaccine supply gap
Bharat Biotech, Bilthoven Biologicals B.V. partner to produce and supply oral polio vaccines
BBIL will procure drug substances for the production of oral polio vaccines to be supplied within India and globally
Bharat Biotech partners with Sydney ID to advance vaccine research in infectious diseases
The international agreement aims to build strong sectoral and cross-organisational collaborations to design novel methodologies to…
UW-Madison Global Health Institute, Ella Foundation to set up UW-Madison One Health Center in India
The UW-Madison Global One Health Center will focus on developing and producing novel vaccines in India
Health minister unveils India’s first intra-nasal COVID vaccine
iNNCOVACC is the world’s first intra-nasal COVID-19 vaccine to receive approval for the primary two-dose schedule, and as a…
Bharat Biotech voluntarily recalls ChiroRabâ vaccine
This action was initiated due to the theft of Chirorabâ from the shipping services provider in Karnataka
First made-in-India intra-nasal COVID vaccine to be launched on R-Day
The nasal vaccine can be taken after six months of the second dose